Docking and QSAR studies of β-phenylethylidenehydrazine derivatives as a Gamma-aminobutyric acid aminotransferase inhibitor

Medicinal Chemistry Research

Volumn 20, Issue 7, 2011, Pages 955-961

  Davood, Asghar ^a   Iman, Maryam ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Docking; Gamma aminobutyric acid aminotransferase (GABA AT); QSAR; Phenylethylidenehydrazine (PEH)

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BETA PHENYLETHYLIDENEHYDRAZINE; ENZYME; HYDRAZINE DERIVATIVE; PHENYL GROUP; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER PROGRAM; CONFORMATION; LIPOPHILICITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 80054751321     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9423-1     Document Type: Article

References (25)

1. Clark M, Cramer RD, Jones DM, Patterson DE, Simeroth PE (1990) Comparative Molecular Field Analysis (CoMFA). 2. Toward its use with 3D-structural databases. Tetrahedron Comput Methodol 3:47-59
2. Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967
3. Davood A, Nematollahi A, Iman M, Shafiee A (2009) Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)- imidazolyl substituent as novel calcium channel agonist. Arch Pharm Res 32:481-487
4. Davood A, Nematollahi A, Iman M, Shafiee A (2010) Computational studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent: QSAR and docking. Med Chem Res 19:58-70
5. Free SMJR, Wilson JW (1964) A mathematical contribution to structure-activity studies. J Med Chem 7:395-399
6. Gaudio AC, Korolkovas A, Takahata Y (1994) Quantitative structure relationships for 1,4-DHP calcium channel. J Pharm Sci 83:1110-1115
7. Gramatica P, Papa E (2003) QSAR modeling of bioconcentration factor by theoretical molecular descriptors. QSAR Comb Sci 22:374-385 (Pubitemid 36717463)
8. Hansch C (1969) A quantitative approach to biochemical structureactivity relationships. Acc Chem Res 2:232-239
9. Hansch C, Fujita T (1964) A method for the correlation of biological activity and chemical structure. J Am Chem Soc 86:1616-1626
10. Hansch C, Leo A (1995) Substituent constants for correlation analysis in chemistry and biology. American Chemical Society, Washington, DC, p 551
11. Hansch C, Kurup A, Garg R, Gao H (2001) Chem-bioinformatics and QSAR. A review of QSAR lacking positive hydrophobic terms. Chem Rev 101:619-672 (Pubitemid 35377680)
12. Huey R, Morris GM (2008) Using Autodock 4 with Autodocktools: A tutorial. 54-56. http://autodock.scripps.edu/faqs-help/tutorial/usingautodock-4-with- autodocktools/UsingAutoDock4WithADT-1.4.5d.pdf.
13. Kubinyi H (1997a) QSAR and 3D QSAR in drug design Part 1: Methodology. Drug Discov Today 2:457-467 (Pubitemid 27450428)
14. Kubinyi H (1997b) Similarity and dissimilarity-a medicinal chemist's view. In: Kubinyi H (ed) 3D QSAR in drug design. ESCOM, Leiden. Drug Discov Today 2:538-546
15. Morris GM, Goodsell DS, Pique ME, Lindstrom WL, Huey R, Forli S, Hart WE, Halliday S, Belew R, Olson AJ (2009) AutoDock 4.2 with AutoDockTools. http://autodock.scripps.edu/faqs-help/ tutorial/using-autodock-4-with- autodocktools/UsingAutoDock4 WithADT-1.4.5d.pdf
16. Patek DR, Hellerman L (1974) Mitochondrial monoamine oxidase: Mechanism of inhibition by phenylhydrazine and by aralkylhydrazines Role of enzymatic oxidation. J Biol Chem 249:2373-2380
17. Popov N, Matthies H (1969) Some effects of monoamine oxidase inhibitors on the metabolism of gamma-aminobutyric acid in rat brain. J Neurochem 16:899-907
18. Sowa B, Rauw G, Davood A, Fassihi A, Knaus EE, Baker GB (2005) Design and biological evaluation of phenyl-substituted analogs of b-phenylethylidene- hydrazine. Bioorg Med Chem 13:4389-4395 (Pubitemid 40813227)
19. Storici P, Capitani G, De Biase D, Moser M, John RA, Jansonius JN, Schirmer T (1999) Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry 38:8628-8634
20. Storici P, De Biase D, Bossa F, Bruno S, Mozzarelli A, Peneff C, Silverman R, Schirmer T (2004) Structures of {gamma}-aminobutyric acid (GABA) aminotransferase, a pyridoxal 50-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with {gamma}-ethynyl-GABA and with the antiepilepsy drug vigabatrin. J Biol Chem 279:363
21. Tipton KF (1972) Inhibition of monoamine oxidase by substituted hydrazines. Biochem J 128:913-919
22. Tipton KF, Spires IP (1972) Oxidation of 2-phenylethylhydrazine by monoamine oxidase. Biochem Pharmacol 21:268-270
23. Todd KG, Baker GB (1995) GABA-elevating effects of the antidepressant/ antipanic drug phenelzine in brain: Effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. J Affect Disord 35:125-129
24. Todeschini R (2008) Milano chemometrics and QSPR group, http://michem.disat.unimib.it/, e-dragon (http://www.vcclab.org/ lab/edragon)
25. Yu PH, Tipton KF (1989) Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity. Biochem Pharmacol 38:4245-4251 (Pubitemid 20009023)